Aarkstore - Hepatitis B - Pipeline Review, H2 2014 - PowerPoint PPT Presentation

About This Presentation
Title:

Aarkstore - Hepatitis B - Pipeline Review, H2 2014

Description:

“Hepatitis B - Pipeline Review, H2 2014”, provides an overview of the Hepatitis Bs therapeutic pipeline. For more details : – PowerPoint PPT presentation

Number of Views:17

less

Transcript and Presenter's Notes

Title: Aarkstore - Hepatitis B - Pipeline Review, H2 2014


1
Aarkstore - Hepatitis B - Pipeline Review, H2 2014
www.aarkstore.com
2
Summary
  • Hepatitis B - Pipeline Review, H2 2014,
    provides an overview of the Hepatitis Bs
  • therapeutic pipeline.
  • This Market Research Report provides
    comprehensive information on the therapeutic
  • development for Hepatitis B, complete with
    comparative analysis at various stages,
  • therapeutics assessment by drug target, mechanism
    of action (MoA), route of administration
  • (RoA) and molecule type, along with latest
    updates, and featured news and press releases. It
  • also reviews key players involved in the
    therapeutic development for Hepatitis B and
    special
  • features on late-stage and discontinued
    projects.

www.aarkstore.com
www.aarkstore.com
3
Scope
  • - The report provides a snapshot of the
    global therapeutic landscape of Hepatitis B- The
    report reviews key pipeline products under drug
    profile section which includes, product
    description, MoA and RD brief, licensing and
    collaboration details other developmental
    activities - The report reviews key players
    involved in the therapeutics development for
    Hepatitis B and enlists all their major and minor
    projects- The report summarizes all the dormant
    and discontinued pipeline projects - A review of
    the Hepatitis B products under development by
    companies and universities/research institutes
    based on information derived from company and
    industry-specific sources- Pipeline products
    coverage based on various stages of development
    ranging from pre-registration till discovery and
    undisclosed stages- A detailed assessment of
    monotherapy and combination therapy pipeline
    projects- Coverage of the Hepatitis B pipeline
    on the basis of target, MoA, route of
    administration and molecule type- Latest news
    and deals relating related to pipeline products

www.aarkstore.com
4
Reasons to buy
  • - Provides strategically significant
    competitor information, analysis, and insights to
    formulate effective RD development strategies-
    Identify emerging players with potentially strong
    product portfolio and create effective
    counter-strategies to gain competitive
    advantage- Develop strategic initiatives by
    understanding the focus areas of leading
    companies- Identify and understand important and
    diverse types of therapeutics under development
    for Hepatitis B- Plan mergers and acquisitions
    effectively by identifying key players of the
    most promising pipeline- Devise corrective
    measures for pipeline projects by understanding
    Hepatitis B pipeline depth and focus of
    Indication therapeutics- Develop and design
    in-licensing and out-licensing strategies by
    identifying prospective partners with the most
    attractive projects to enhance and expand
    business potential and Scope- Modify the
    therapeutic portfolio by identifying discontinued
    projects and understanding the factors that drove
    them from pipeline

www.aarkstore.com
5
Table of Contents
  • Introduction 11Global Markets Direct
    Report Coverage 11Hepatitis B Overview
    12Therapeutics Development 13Pipeline Products
    for Hepatitis B - Overview 13Pipeline Products
    for Hepatitis B - Comparative Analysis
    14Hepatitis B - Therapeutics under Development
    by Companies 15Hepatitis B - Therapeutics under
    Investigation by Universities/Institutes
    23Hepatitis B - Pipeline Products Glance 24Late
    Stage Products 24Clinical Stage Products
    25Early Stage Products 26

www.aarkstore.com
6
List Of Tables
  • Number of Products under Development for
    Hepatitis B, H2 2014 21Number of Products under
    Development for Hepatitis B - Comparative
    Analysis, H2 2014 22Number of Products under
    Development by Companies, H2 2014 24Number of
    Products under Development by Companies, H2 2014
    (Contd..1) 25Number of Products under
    Development by Companies, H2 2014 (Contd..2)
    26Number of Products under Development by
    Companies, H2 2014 (Contd..3) 27Number of
    Products under Development by Companies, H2 2014
    (Contd..4) 28Number of Products under
    Development by Companies, H2 2014 (Contd..5)
    29Number of Products under Development by
    Companies, H2 2014 (Contd..6) 30Number of
    Products under Investigation by
    Universities/Institutes, H2 2014 31

www.aarkstore.com
7
List Of Figures
  • Number of Products under Development for
    Hepatitis B, H2 2014 21Number of Products under
    Development for Hepatitis B - Comparative
    Analysis, H2 2014 22Number of Products under
    Development by Companies, H2 2014 23Number of
    Products under Investigation by
    Universities/Institutes, H2 2014 31Comparative
    Analysis by Late Stage Development, H2 2014
    32Comparative Analysis by Clinical Stage
    Development, H2 2014 33Comparative Analysis by
    Early Stage Products, H2 2014 34Assessment by
    Monotherapy Products, H2 2014 116Assessment by
    Combination Products, H2 2014 117Number of
    Products by Top 10 Targets, H2 2014 118

www.aarkstore.com
8
Related Market Research reports
  • Corticosteroid-Responsive Dermatoses - Pipeline
    Review, H1 2014
  • Hematological Tumor - Pipeline Review, H1 2014
  • Inflammation - Pipeline Review, H1 2014
  • Opioid Induced Side Effects - Pipeline Review, H1
    2014
  • Skin Infections - Pipeline Review, H1 2014

www.aarkstore.com
9
Related Market Research reports
  • Restenosis - Pipeline Review, H1 2014
  • Tauopathies - Pipeline Review, H1 2014
  • Nasopharyngitis (Common Cold) - Pipeline Review,
    H1 2014
  • Mucopolysaccharidosis III (MPS III) (Sanfilippo
    Syndrome) - Pipeline Review, H1 2014
  • Chemotherapy Induced Peripheral Neuropathy -
    Pipeline Review, H1 2014

www.aarkstore.com
10
Aarkstore - Hepatitis B - Pipeline Review, H2 2014
Format Price
PDF 2000
Site Licence 4000
Enterprise Wide Licence  6000
www.aarkstore.com
11
Contact Us
  • Office
  • Office No. - 809, 8th Floor,
  • B-Wing, Mahaavir Icon, 
  • Plot No.- 89 90, Sector-15,
  • CBD-Belapur, Navi Mumbai 400614, 
  • Maharashtra, India.
  • 24/7 Online Support 91 9987295242
  • General Inquiries 91 - 22 2756 4953
  • You Can Visit http//www.aarkstore.com
  • OR Mail us at contact_at_aarkstore.com
  • Blog http//www.aarkstore.com/blog/
  • Conference http//conference.aarkstore.com/
  • News http//www.aarkstore.com/news

www.aarkstore.com
Write a Comment
User Comments (0)
About PowerShow.com